Trial intelligence / Profile preview

Aqueous versus aerosol beclomethasone sprays in nasal polyps

IRCT20171030037093N32Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Feb 2020
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial of beclomethasone in nasal polyp (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Sino-Nasal Outcome Test-22 score and Lund-Mackay score. Started Feb 2020; status: completed.

02

Drugs

beclomethasone
03

Conditions

nasal polyp

Beyond the preview

Go deeper on IRCT20171030037093N32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20171030037093N32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call